Tests head acupuncture after clot removal for acute ischemic stroke
Tests head acupuncture with clot removal in adults with acute stroke.
Key facts
- Who runs it
- Xi'an No.3 Hospital
- Where
- Xi'an, ChinaSee the site
- Trial code
- Registry title
- Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke
- Status
- Recruiting
- People taking part
- 272 people, planned
- Started
- 27 Apr 2023
- Expected to end
- 31 Oct 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- Scalp Acupuncture
- The treatment recommended in the guidelines for acute ischemic stroke was administered
- Record updated
- 12 May 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with acute ischemic stroke who had a procedure to remove the clot (endovascular treatment) within 24 hours of onset. It tests head acupuncture added to this treatment.
- Age
- 18 to 100 years
- Sex
- All sexes can join.
- Disease stage
- Acute ischemic stroke treated within 24 hours of onset; NIHSS score above 6 and up to 25; ASPECT score of 6 points or more.
- Earlier treatment
- Must have received endovascular treatment within 24 hours of stroke onset.
Main reasons for not taking part
- Brain tumor or bleeding in the brain on CT or MRI
- Contraindications to contrast media
- Dementia or mental illness that prevents cooperating with treatment and follow-up
- Expected survival of less than 3 months
- Pregnant, planning pregnancy or breastfeeding women
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Age ≥18 years
- Patients with acute ischemic stroke who received endovascular treatment within 24 hours of onset
- 6 < NIHSS ≤25
- ASPECT score ≥6 points
- Signed Informed consent
Who cannot take part
- CT or brain MRI confirmed intracranial tumor and intracranial hemorrhage
- Dementia or mental illness，unable to cooperate with treatment and follow-up
- Contraindications of contrast media
- The expected survival time was less than 3 months
- Women who are pregnant, planning to become pregnant or breastfeeding
- Currently participating in other clinical trials
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 100 years old?
Where in China
- Xi 'an No.3 HospitalXi'an, ChinaContact: Shilin Li, DoctorTaking people
About the trial
What the trial wants to find out
To evaluate the efficacy and safety of head acupuncture combined with endovascular therapy for cerebral infarction compared with endovascular therapy alone
The 2 groups in the trial
- experimental groupTreatment being tested
Mechanical thrombectomy was followed by acupuncture and guideline-based conventional treatment
Treatment: Scalp Acupuncture and The treatment recommended in the guidelines for acute ischemic stroke was administered
- control groupTreatment being tested
Conventional treatment based on guidelines was administered after mechanical thrombectomy
Treatment: The treatment recommended in the guidelines for acute ischemic stroke was administered
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- A Single-center, Prospective, Randomized, Controlled Study of Mechanical Thrombectomy Followed by Acupuncture for Acute Ischemic Stroke
- Plain-language title
- Tests head acupuncture after clot removal for acute ischemic strokeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT05561088, who can take part
- Record updated
- 12 May 2023